Loading
institutionsInstitution
Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille
Marseille's university hospital, where Jean-Jacques Grob's dermatology department, Olivier Chinot's neuro-oncology unit and Florence Duffaud's sarcoma group have each led international trials.
Also called: AP-HMLa TimoneCHU de MarseilleAix-Marseille University Hospital
Overview
Hôpital de la Timone is the largest hospital of Assistance Publique-Hôpitaux de Marseille and the main teaching hospital of Aix-Marseille University. Its Department of Dermatology and Skin Cancer under Jean-Jacques Grob led KEYNOTE-629 in cutaneous squamous-cell carcinoma and contributed to the major melanoma trials; the neuro-oncology unit under Olivier Chinot led AVAglio in glioblastoma; and the medical oncology department under Florence Duffaud coordinated the French Sarcoma Group's REGOBONE trial in bone sarcomas. The Institut Paoli-Calmettes, the region's dedicated cancer centre, is a separate institution across the city.
Location
Marseille, FR
Type
hospital · Aix-Marseille Université
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#438 · 10 points (0 Newsweek + 0 NCI + 10 from 5 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Assistance Publique Hôpitaux de Marseille, including child institutions. 509 works · 5,706 citations · 66% open access · 17% clinical trials · 2% reviews.
Oncology works per year
1002022
1012023
1152024
1232025
702026
Most works
- Jean‐Jacques Grob49 works
- Laurent Greillier48 works
- Paolo A. Ascierto35 works
- Stéphane Dalle33 works
- Caroline Gaudy‐Marqueste29 works
- Georgina Venetia Long29 works
- Célèste Lebbé24 works
- Lionel Falchero24 works
- Michele Del Vecchio22 works
- Caroline Dutriaux22 works
Most cited
- Dermato-oncology
- Neuro-oncology
- Sarcoma (French Sarcoma Group)
Florence Duffaud
Medical oncologist, Hôpital de la Timone, Aix-Marseille University
Bone sarcomaGastrointestinal stromal tumourKinase inhibitors in sarcoma
Marseille oncologist who led REGOBONE, the trial that showed regorafenib delays progression in metastatic osteosarcoma and other bone sarcomas.
Jean-Jacques Grob
Professor of Dermatology, Aix-Marseille University, Hôpital de la Timone
MelanomaCutaneous squamous-cell carcinomaAdjuvant immunotherapy
Marseille dermatologist who led KEYNOTE-629, which established pembrolizumab for advanced cutaneous squamous-cell carcinoma, and who has been a senior investigator on many European melanoma trials.
Olivier L. Chinot
Neuro-oncologist, Aix-Marseille University and Hôpital de la Timone
GlioblastomaAnti-angiogenic therapyNeuro-oncology trials
Marseille neuro-oncologist who was lead author of AVAglio, the trial that showed adding bevacizumab to standard glioblastoma treatment delays progression but does not lengthen life.
Similar pages
- Key paperKEYNOTE-629: pembrolizumab monotherapy for recurrent or metastatic cutaneous squamous cell carcinoma
Shares Jean-Jacques Grob, Advanced cutaneous squamous cell carcinoma.
- TrialAVAglio
Shares Olivier L. Chinot, Glioma & glioblastoma.
- TrialREGOBONE
Shares Florence Duffaud, Osteosarcoma.
- TreatmentCobolimab
Shares Osteosarcoma, Glioma & glioblastoma, Melanoma.
- TargetERCC2
Shares Osteosarcoma, Melanoma.
- TrialA Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
Shares Osteosarcoma, Melanoma.
- CancerChondrosarcoma
Shares Florence Duffaud, Osteosarcoma.
- TreatmentVusolimogene oderparepvec
Shares Advanced cutaneous squamous cell carcinoma, Melanoma.